tradingkey.logo
tradingkey.logo
검색

Harvard Bioscience Inc

HBIO
관심 목록에 추가
6.050USD
-0.100-1.63%
종가 07/01, 16:00ET시세는 15분 지연됩니다
27.29M시가총액
손실P/E TTM

Harvard Bioscience Inc

6.050
-0.100-1.63%

자세한 내용은 Harvard Bioscience Inc 회사

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Harvard Bioscience Inc 정보

종목 코드 HBIO
회사 이름Harvard Bioscience Inc
상장일Oct 21, 2013
CEODuke (John D)
직원 수330
유형Ordinary Share
회계 연도 종료Oct 21
주소84 October Hill Rd
도시HOLLISTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01746-1371
전화15088938999
웹사이트https://www.harvardbioscience.com/
종목 코드 HBIO
상장일Oct 21, 2013
CEODuke (John D)

Harvard Bioscience Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
58.67K
+28.22%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
27.56K
+60.08%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
26.56K
+62.34%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
58.67K
+28.22%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
27.56K
+60.08%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
26.56K
+62.34%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

자주 묻는 질문

Harvard Bioscience Inc의 상위 5대 주주는 누구인가요?

Harvard Bioscience Inc의 상위 5대 주주는 다음과 같습니다: Ms. Katherine Anne Eade, J.D.

Harvard Bioscience Inc(HBIO)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Harvard Bioscience Inc의 주식을 보유한 기관은 총 201곳이며, 이들이 보유한 주식의 총 가치는 약 2.44M로 전체 발행 주식의 54.17%를 차지합니다. 이는 2025Q4 대비 -447956.00 증가한 수치입니다.

Harvard Bioscience Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Harvard Bioscience Inc의 Instruments, equipment, software and accessories 부문이 가장 높은 매출을 기록했으며, 금액은 78.26M로 전체 매출의 90.42%를 차지했습니다.